Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations

Pediatrics

Volumn 115, Issue 6, 2005, Pages 1479-1487

  Broder, Karen R ^a,b   MacNeil, Adam ^a,c   Malone, Shauna ^a   Schwartz, Benjamin ^a   Baughman, Andrew L ^a   Murphy, Trudy V ^a   Pickering, Larry K ^a   Moran, John S ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Adherence; Pneumococcal conjugate vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE; BACTERIAL POLYSACCHARIDE; PNEUMOCOCCAL POLYSACCHARIDE, TYPE 7; VACCINE;

FEMALE; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; MALE; MEDICAL PRACTICE; ORGANIZATION AND MANAGEMENT; OTITIS MEDIA; PARENT; PEDIATRICIAN; PRIORITY JOURNAL; REVIEW; VACCINATION; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HEALTH CARE ORGANIZATION; IMMUNOLOGY; INFORMATION PROCESSING; INTERNAL MEDICINE; PEDIATRICS; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; SOCIAL JUSTICE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE RATIONING; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INSURANCE, HEALTH; INTERNAL MEDICINE; MALE; PEDIATRICS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; PRACTICE GUIDELINES; PRIVATE SECTOR; PROFESSIONAL PRACTICE; PUBLIC SECTOR; SAMPLING STUDIES; SOCIAL JUSTICE; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 27744486267     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1617     Document Type: Review

References (36)

1. Centers for Disease Control and Prevention. Shortage of tetanus and diphtheria toxoids [published correction appears in MMWR Morb Mortal Wkly Rep. 2001;50:126]. MMWR Morb Mortal Wkly Rep. 2000;49:1029-1030
2. Centers for Disease Control and Prevention. Update on the supply of tetanus and diphtheria toxoids and the diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:189-190
3. Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783-784
4. Centers for Disease Control and Prevention. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51:190-191
5. Centers for Disease Control and Prevention. 2004 childhood and adolescent immunization schedule. Available at: www.cdc.gov/nip/recs/child-schedule. htm#Printable. Accessed June 8, 2004
6. Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortages - Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50:1140-1142
7. Overturf GD. New recommendations for pneumococcal conjugate vaccine in a setting of vaccine shortages. AAP News. January 2002
8. Preboth M. Vaccine shortages and delays continue in 2002. Available at: www.findarticles.com/cfdls/m3225/865/85285629/p1/article.jhtml. Accessed June 8, 2004
9. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366
10. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49(RR-9):1-38
11. Centers for Disease Control and Prevention. Pneumococcal conjugate vaccine shortage resolved. MMWR. 2003;52:446-447
12. American Academy of Pediatrics. Demographic characteristics. Available at: www.aap.org/womenpeds/demographics2003.doc. Accessed June 7, 2004
13. Centers for Disease Control and Prevention. Vaccines for Children program. Available at: www.cdc.gov/nip/vfc. Accessed May 5, 2004
14. Freed GL, Davis MM, Clark JS. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA. 2003;289:575-578
15. Stokely S., Santoli JM, Bayo W, Vanda K, Vargas-Rosales A, Rodewald LE. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med. 2004;26:15-21
16. Zun LS, Downey L. Tetanus immunization shortage in the United States. Am J Emerg Med. 2003;21:298-301
17. Mary RC, Abrahmse AF, Hirsch SH, Frank JC, Reuben DB. What influences physician practice behavior? An interview study of physicians who received consultative geriatric assessment recommendations. Arch Fam Med. 1996;5:448-454
18. Ely JW, Goerdt CJ, Bergus GR, West CP, Dawson JD, Doebbeling BN. The effect of physician characteristics on compliance with adult preventive care guidelines. Fam Med. 1998;30:34-39
19. Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract. 1992;5:143-152
20. Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract. 2003;16:363-371
21. Winkler JD, Lohr KN, Brook RH. Persuasive communication and medical technology assessment. Arch Intern Med. 1985;145:314-317
22. Beaulieu MD, Hudon E, Roberge D, Pineault R, Forte D, Legare J. Practice guidelines for clinical prevention: do patients, physicians and experts share common ground? CMAJ. 1999;161:519-523
23. Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53:177
24. Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder/recall interventions on immunization rates: a review. JAMA. 2000;284:1820-1827
25. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services. MMWR Recomm Rep. 1999;48(RR-8):1-15
26. Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics. 2003;112:1076-1082
27. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129-1136
28. Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res. 2001;35:1347-1355
29. McPhillips HA, Davis RL, Marcuse EK, Taylor JA. The rotavirus vaccine's withdrawal and physician's trust in vaccine safety mechanisms. Arch Pediatr Adolesc Med. 2001;155:1051-1056
30. Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine. Pediatrics. 2003;112:521-526
31. United States General Accounting Office, Report to congressional requesters. Childhood vaccines: ensuring an adequate supply poses continuing challenges. Available at: www.gao.gov/new.items/d02987.pdf. Accessed June 8, 2004
32. Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290:3122-3128
33. Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine: suspension of recommendation for fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53:108-109
34. Centers for Disease Control and Prevention. Why your child may have to wait to get his or her third or fourth dose of Prevnar vaccine: facts for parents. Available at: www.cdc.gov/nip/news/shortages/pcv7_parent_3-1-04.pdf. Accessed May 11, 2004
35. Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2003;52:1234
36. Centers for Disease Control and Prevention. Pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep. 2004;53:851-852